FDA
-
-
-
-
-
-
-
Beyond Air Expands Commercial Access for LungFit® PH Through a Purchasing Agreement with a Top 3 National Group Purchasing Organization (GPO)
-
-
-
-
-
-
-
Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd.
-
-
-
-
-
-
-
Beyond Air Schedules Third Fiscal Quarter 2026 Financial Results Conference Call and Webcast
-
-
-
-
-
-
-
Beyond Air names Dan Moorhead as chief financial officer
-
-
-
-
-
-
-
Beyond Air secures $32 million financing from Streeterville Capital
-
-
-
-
-
-
-
NeuroNOS Granted FDA Orphan Drug Designation for Glioblastoma, the Most Common and Deadliest Primary Malignant Brain Cancer in Adults
-
-
-
-
-
-
-
Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc.
-
322,090 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

